Related Experiment Video
Updated: Aug 23, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Primary prevention of sudden cardiac death
1University of Pittsburgh School of Medicine, PUH B535, 200 Lothrop Street, Pittsburgh, PA 15213, USA. ganzl@msx.upmc.edu
Insights
Sudden cardiac death (SCD) is a leading cause of death. Prophylactic implantation of implantable cardioverter defibrillators (ICDs) in high-risk patients with cardiomyopathy improves survival and reduces SCD incidence.
Area of Science:
- Cardiology
- Public Health
- Medical Technology
Background:
- Sudden cardiac death (SCD) is the primary cause of mortality in the U.S.
- SCD often occurs in individuals with pre-existing heart conditions but can be the first sign of cardiovascular disease.
- Effective strategies are crucial for reducing SCD rates.
Purpose of the Study:
- To review strategies for reducing sudden cardiac death incidence.
- To highlight the role of implantable cardioverter defibrillators (ICDs) in preventing SCD.
- To identify patient populations who benefit from prophylactic ICD implantation.
Main Methods:
- Review of current pharmacologic and nonpharmacologic treatments for heart disease and risk factors.
- Analysis of public health initiatives for cardiac arrest response, including automated external defibrillators.
- Evaluation of clinical trial data on prophylactic ICD implantation in high-risk cardiomyopathy patients.
Main Results:
- Aggressive management of heart disease and its risk factors is essential.
- Community-based automated external defibrillator programs significantly improve cardiac arrest survival.
- Clinical trials confirm that prophylactic ICD implantation improves survival in patients with ischemic and nonischemic cardiomyopathy.
Conclusions:
- Reducing sudden cardiac death requires a multifaceted approach.
- Implantable cardioverter defibrillators are a vital tool for preventing SCD in high-risk individuals.
- Continued research and implementation of evidence-based strategies are necessary to further decrease SCD mortality.
Abstract:
Sudden cardiac death (SCD) is the leading cause of death in the United States. Although SCD occurs most commonly in patients with established heart disease, SCD can also be the initial manifestation of cardiovascular disease. Efforts to reduce the incidence of SCD include aggressive treatment of heart disease and its risk factors with pharmacologic and nonpharmacologic strategies. Public health measures to improve the response to cardiac arrest, including dissemination of automated external defibrillators in the community, are extremely important. Implantation of implantable cardioverter defibrillators (ICDs) in patients at high risk of SCD improves survival in these patients. Clinical trials have identified patients with ischemic and nonischemic cardiomyopathy who may benefit from prophylactic ICD implantation.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiopulmonary Resuscitation III: AED Use
Introduction Cardiac Emergencies
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...

